![Ajanta Pharma Share Price Ajanta Pharma Share Price](https://images.5paisa.com/MarketIcons/AJANTPHARM.png)
Ajanta Pharma Share Price
Start SIP in Ajanta Pharma
Start SIPAjanta Pharma Performance
Day Range
- Low 3,292
- High 3,409
52 Week Range
- Low 1,650
- High 3,409
- Open Price3,345
- Previous Close3,330
- Volume255583
Ajanta Pharma Investment Rating
-
Master Rating:
-
Ajanta Pharma has an operating revenue of Rs. 4,332.59 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 26% is great, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 24% and 44% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 31% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 1,077 | 926 | 1,085 | 945 | 1,015 | 849 |
Operating Expenses Qtr Cr | 761 | 699 | 758 | 672 | 738 | 704 |
Operating Profit Qtr Cr | 316 | 227 | 327 | 274 | 277 | 145 |
Depreciation Qtr Cr | 33 | 33 | 33 | 33 | 32 | 32 |
Interest Qtr Cr | 1 | 1 | 2 | 2 | 1 | 1 |
Tax Qtr Cr | 75 | 63 | 85 | 78 | 63 | 31 |
Net Profit Qtr Cr | 236 | 163 | 220 | 212 | 212 | 117 |
Ajanta Pharma Technicals
EMA & SMA
![pointer pointer](https://cdn-static.trendlyne.com/static/img/brokerwebview/pointer.png)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹3,086.58
- 50 Day
- ₹2,822.52
- 100 Day
- ₹2,597.05
- 200 Day
- ₹2,342.51
- 20 Day
- ₹3,109.88
- 50 Day
- ₹2,697.51
- 100 Day
- ₹2,510.14
- 200 Day
- ₹2,305.88
Ajanta Pharma Resistance and Support
Resistance | |
---|---|
First Resistance | 3,409.15 |
Second Resistance | 3,467.95 |
Third Resistance | 3,526.50 |
RSI | 71.89 |
MFI | 84.01 |
MACD Single Line | 153.47 |
MACD | 158.36 |
Support | |
---|---|
First Support | 3,291.80 |
Second Support | 3,233.25 |
Third Supoort | 3,174.45 |
Ajanta Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 262,921 | 12,741,152 | 48.46 |
Week | 192,476 | 8,875,087 | 46.11 |
1 Month | 253,699 | 10,622,381 | 41.87 |
6 Month | 182,385 | 8,404,315 | 46.08 |
Ajanta Pharma Result Highlights
Ajanta Pharma Synopsis
NSE-Medical-Generic Drugs
Ajanta Pharma Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3971.12 Cr. and Equity Capital is Rs. 25.27 Cr. for the Year ended 31/03/2024. Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059.Market Cap | 41,850 |
Sales | 4,034 |
Shares in Float | 4.25 |
No of funds | 290 |
Yield | 1.07 |
Book Value | 12.4 |
U/D Vol ratio | 2.7 |
LTDebt / Equity | |
Alpha | 0.25 |
Beta | 0.27 |
Ajanta Pharma Shareholding Pattern
Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|
Promoters | 66.27% | 66.21% | 66.21% | 66.21% |
Mutual Funds | 14.84% | 14.76% | 13.86% | 12.84% |
Insurance Companies | 2.2% | 2.16% | 2.15% | 2.07% |
Foreign Portfolio Investors | 8.36% | 8.54% | 9.11% | 9.99% |
Financial Institutions/ Banks | ||||
Individual Investors | 7.08% | 6.91% | 7.07% | 7.21% |
Others | 1.25% | 1.42% | 1.6% | 1.68% |
Ajanta Pharma Management
Name | Designation |
---|---|
Mr. Mannalal B Agrawal | Chairman |
Mr. Madhusudan B Agrawal | Vice Chairman |
Mr. Yogesh M Agrawal | Managing Director |
Mr. Rajesh M Agrawal | Joint Managing Director |
Mr. K H Viswanathan | Independent Director |
Mr. Prabhakar R Dalal | Independent Director |
Dr. Anjana Grewal | Independent Director |
Mr. Chandrakant M Khetan | Independent Director |
Ajanta Pharma Forecast
Price Estimates
Ajanta Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-07-30 | Quarterly Results | |
2024-05-02 | Audited Results & Buy Back of Shares | |
2024-01-31 | Quarterly Results & 2nd Interim Dividend | |
2023-10-31 | Quarterly Results | |
2023-07-27 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2024-02-08 | INTERIM | Rs.26.00 per share(1300%)Second Interim Dividend |
2023-08-04 | SPECIAL | Rs.15.00 per share(750%)Special Dividend |
2023-08-04 | INTERIM | Rs.10.00 per share(500%)First Interim Dividend |
2022-11-14 | INTERIM | Rs.7.00 per share(350%)Interim Dividend |
2021-11-10 | INTERIM | Rs.9.50 per share(475%)Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2022-06-23 | Bonus | Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-. |
Ajanta Pharma FAQs
What is Share Price of Ajanta Pharma ?
Ajanta Pharma share price is ₹3,350 As on 08 September, 2024 | 07:02
What is the Market Cap of Ajanta Pharma ?
The Market Cap of Ajanta Pharma is ₹41849.9 Cr As on 08 September, 2024 | 07:02
What is the P/E ratio of Ajanta Pharma ?
The P/E ratio of Ajanta Pharma is 49 As on 08 September, 2024 | 07:02
What is the PB ratio of Ajanta Pharma ?
The PB ratio of Ajanta Pharma is 11.8 As on 08 September, 2024 | 07:02